Equine Veterinary Therapeutic Trends and Forecast
The future of the global equine veterinary therapeutic market looks promising with opportunities in the veterinary hospital, veterinary clinic, pharmacy and drug store, and e-commerce markets. The global equine veterinary therapeutic market is expected to grow with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are rise in horse racing and other equestrian activities, the growing prevalence of equine ailments, and the rising costs associated with novel treatments' research and development.
• Lucintel forecasts that topical is expected to witness the highest growth over the forecast period due to growing demand for anti-infectives, pain relievers, and digestive aid products.
• North America will remain the largest region over the forecast period due to growing demanf for anti-infectives, vaccinations, pain medications, digestive aids, and strong research and development industry in the region.
A more than 150-page report is developed to help in your business decisions.
Country Wise Outlook for the Equine Veterinary Therapeutic Market
The equine veterinary therapeutics market is well advancing due to increased awareness regarding equine health and investitures in animal care. Advances in formulation of drugs, diagnostic equipment, and treatment methodologies are improving the quality of care for horses. Changes in regulatory matters and growing demand for preventive healthcare also shape the market dynamics across key regions, such as the United States, China, Germany, India, and Japan.
• United States: Equine veterinary therapeutics markets in the United States are rapidly growing, with novel developments in areas like pain management and joint health. Companies are creating more advanced formulations, such as biologics and regenerative therapies, to combat conditions like osteoarthritis. Telemedicine consultations and follow-ups are on the rise, and veterinary care is becoming more accessible. Regulatory authorities are also updating guidelines proactively, making it easier for new equine drugs and therapeutics to receive approval.
• China: Equine veterinary markets in China have been rising with the country making increasingly larger investments in equine sports and leisure activities. The government encourages research and development in veterinary medicines through new therapies; there is growing demand for preventive care, and more horse owners are being vaccinated and supplemented. Moreover, the collaboration between local firms and international firms is bolstering advanced therapeutics to the Chinese market and, as such, improves the general management of horses' health.
• Germany: Germany is involved in creating green and reliable equine therapeutics, where research is conducted on preventive health and welfare. Innovation has been seen in new vaccines and nutraceuticals for enhanced performance of horses and general well-being. The regulatory institutions are streamlining the approval process of new veterinary medicines, thus fostering healthy growth in the market. The country has numerous equine health conferences that bridge veterinarians with researchers to bring about better therapeutic options for equines.
• India: Indian equine veterinary therapeutics The market is quite dynamic with a surge in equine events and the rise in concern for the welfare of horses. The introduction of relatively affordable options in therapeutics brings access to the care of veterinarians to horse owners. Colligation with global companies is providing improved treatment options, thereby enhancing the availability of advanced treatments. Manufacturers are focused on introducing the production of customized vaccines and supplements in India, accommodating the needs of Indian horses, thus bettering health outcomes in the equine population.
• Japan: This is an extremely innovative and quality-sensitive market in Japan. The newest products relate to state-of-the-art pain management therapies as well as nutrient supplements. The Japanese government is promoting veterinary research to formulate new equine care treatments. Furthermore, the growing popularity of equestrian activities has enhanced the demand for specialty therapeutics. Equine clinics are adopting high-tech diagnostic equipment to improve the accuracy of treatment and effectiveness in their care.
Emerging Trends in the Equine Veterinary Therapeutic Market
Equine veterinary therapeutics experience several emerging trends changing the landscape and horse health issues.
• Preventive care: There is an increased focus on preventive healthcare in equine medicine, which is a reflection of better handling of disease management. Expenditure on vaccination and health check-ups by horse owners has been on the rise lately as people prevent illnesses before they come up. The final result is a healthy population of equines and lower expenditure on treatment in the long run.
• Enhanced Regenerative Medicine: Equine injury treatments have been completely revolutionized by regenerative therapies, such as stem cell treatments and platelet-rich plasma (PRP) injections. This way, with new approaches, wound healing and recovery times become much more favorable for such conditions as tendon injuries and osteoarthritis.
• Adoption of Telemedicine: Telemedicine has revolutionized veterinary consultations through remote assessment and follow-ups for equine patients. Additionally, it improves access to veterinary care in rural areas, without the burden of traveling while ensuring necessary interventions are attended to.
• Sustainable Veterinary Practice: Development of equine therapeutics would gradually tend towards sustainability. This shift would attract more conscious consumers to the brands, and increased brand loyalty would result. More companies are now focusing on manufacturing processes and materials that are not harmful to the environment, promoting a broader concern that relates directly to the responsibility of the industry regarding the environment.
• Use of Technology in Diagnosis: Improved technology aspects lead to a better means of diagnosis, for instance, imaging and mobile applications used in health monitoring. This leads to a more accurate diagnosis within the shortest time, hence improving treatment outcomes and equine health management.
These trends combine in boosting the equine veterinary therapeutics market. Health outcomes in horses are getting better with constant innovation by equine industry members.
Recent Developments in the Equine Veterinary Therapeutic Market
The equine veterinary therapeutics market has several significant developments that could impact treatment options and, in general, equine health.
• New Biologics Development: The novelty brought by new biologics, such as certain monoclonal antibodies dedicated to equine diseases, represents the first time for a targeted approach. Improved efficacy and fewer side effects result in new possibilities in the therapeutic landscape for equine practitioners.
• Advanced Nutraceuticals: Also, the area of nutraceuticals applied for improving performance and enhancing recovery shows to be an important current development. Nutraceuticals are products derived from natural sources designed to support joint health and, more generally, wellness and thus meet a significant demand for alternative therapies.
• Improvements in Regulation: Regulatory bodies are making it easier to allow rapid clearance of new equine therapeutics by streamlining approval processes, encouraging companies to invest in research and development and, hence, fostering a more dynamic landscape of therapeutics.
• Research and Development Investment: Increased funding for equine health research is a source of breakthrough in treatment methodologies. Collaboration among universities, veterinary practices, and pharmaceutical companies has developed innovation and broadened the scope of the therapeutics available.
• Smart Technology Usage: The total use of smart technology, including wearable health monitors for equines, makes a way for preventive care and monitoring of treatments. Such technologies provide veterinarians with real-time data that increases the chances of an accurate diagnosis and customized treatment plan.
This type of trend in the equine veterinary therapeutics market is accordingly meaningfully shaping the treatment modalities, as it provides greater access to treatment and encourages novel approaches in managing equine health.
Strategic Growth Opportunities for Equine Veterinary Therapeutic Market
There are several strategic growth opportunities available in the equine veterinary therapeutics market that could spur innovation and expand access to care.
• Rise of Online Veterinary Services: Telemedicine presents a possibility to expand access to veterinary care on the part of horse owners, particularly those residing in rural locations. Remote consultations by online platforms enhance patient activation and treatment adherence.
• Focus on Performance Horses: The performance horse market can be projected as in growth due to the nature of race horses and show jumpers. With this kind of market, one's mind immediately creates a therapeutic need when answering the requirements of health or performance. Upon this need, demand follows for such a customized treatment.
• New Product Innovation: New and improved therapeutics, in the form of biologics and nutraceuticals, may result from research investments aimed at fulfilling the unserved needs in equine health. Innovation focus can make a company more prominent in the equine veterinary market.
• Collaborative Research Programs: Innovative equine therapeutics may result from entering into joint ventures with universities and research centers. Collaborative programs may thus end in the establishment of leading-edge treatments and contribute toward strengthening the market position.
• Increasing Awareness Campaigns: Educational efforts related to equine health and available therapeutic treatments will be able to educate the owner who may then seek treatment and, hence demand it. Owner awareness would likely lead to a more proactive approach toward ensuring better health care for his equine and more purchases of veterinary products.
Growth opportunities, as identified above, are essential to propel the equine veterinary therapeutics market forward, ensuring better health outcomes for equines, and positioning companies in a competitive landscape for increased success.
Equine Veterinary Therapeutic Market Driver and Challenges
The growth of the equine veterinary therapeutics market is influenced by myriad factors that, in turn, affect this market's growth trajectory. Understanding these factors becomes a pivotal aspect for stakeholders in this market as it is highly dynamic in the present times.
The factors responsible for driving the equine veterinary therapeutic market include:
1. Improved Health Awareness of Equine Animals: The growth in health management awareness among horse owners enhances the rising demand for veterinary therapeutics. Thus, owners start to look for better care options, which in turn makes the market for innovative treatments grow.
2. Development in Veterinary Medicines: Continuous discoveries in veterinary medicine, mainly the invention of new drugs and treatments, develop equine therapies to improve efficacy. Thus, they draw veterinarians and horse owners toward the modern treatment.
3. Increased Investment in Equine Healthcare: More investment in equine health and particularly sporting and leisure-related equine activities are pushing the demand for veterinary therapeutics forward. Increased employment in the equine sector raises more health needs in the equine business.
Challenges in the equine veterinary therapeutic market are:
1. Rising Cost of Sophisticated Treatments: Most advanced veterinary therapeutics are costly, and that will limit access to some equine owners. The affordability of the product is an essential thing in ensuring expanded use among the people in the market.
2. Rural Regions Have Limited Knowledge of New Therapeutic Options and Technologies: The areas of residence in the rural regions might not have awareness of the most recently developed therapeutic options and technologies. There are aspects of knowledge to be covered or bridged in the areas in order to improve the management of health in equines.
3. Stringent Regulatory Requirements: Whereas regulatory support from demand-side factors exists, extremely stringent regulations to enter the market can be a deterrent. The regulations are quite complex and require a high investment and time for entry into the market.
The growth paths and strategic moves in the equine veterinary therapeutics market are determined by the drivers and challenges. This interplay of consumer demand, technological support, and a regulatory environment will continue to shape the market dynamics, thus opening doors to opportunities and obstacles for the stakeholders.
List of Equine Veterinary Therapeutic Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies equine veterinary therapeutic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the equine veterinary therapeutic companies profiled in this report include-
• Merck Animal Heath
• Affymetrix
• Elanco Animal Health
• Zoetis (Pfizer Animal Health)
• Equine Health
Equine Veterinary Therapeutic by Segment
The study includes a forecast for the global equine veterinary therapeutic by drug, vaccines, route of administration, distribution channel, and region.
Equine Veterinary Therapeutic Market by Drug [Analysis by Value from 2018 to 2030]:
• Anti- Inflammatory
• Anti - Infective
• Parasiticides
• Others
Equine Veterinary Therapeutic Market by Vaccines [Analysis by Value from 2018 to 2030]:
• Recombinant vaccines
• Inactivated Vaccines
• Live Attenuated Vaccines
• Others
Equine Veterinary Therapeutic Market by Route of Administration [Analysis by Value from 2018 to 2030]:
• Oral
• Parental
• Topical
Equine Veterinary Therapeutic Market by Distribution Channel [Analysis by Value from 2018 to 2030]:
• Veterinary Hospital
• Veterinary Clinics
• Pharmacies & Drug stores
• E-Commerce
• Others
Equine Veterinary Therapeutic Market by Region [Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Equine Veterinary Therapeutic Market Insights
• Lucintel forecasts that topical is expected to witness the highest growth over the forecast period due to growing demand for anti-infectives, pain relievers, and digestive aid products.
• North America will remain the largest region over the forecast period due to growing demanf for anti-infectives, vaccinations, pain medications, digestive aids, and strong research and development industry in the region.
Features of the Global Equine Veterinary Therapeutic Market
Market Size Estimates: Equine veterinary therapeutic market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Equine veterinary therapeutic market size by drug, vaccines, route of administration, distribution channel, and region in terms of value ($B).
Regional Analysis: Equine veterinary therapeutic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drug, vaccines, route of administration, distribution channel, and regions for the equine veterinary therapeutic market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the equine veterinary therapeutic market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q1. What is the growth forecast for equine veterinary therapeutic market?
Answer: The global equine veterinary therapeutic market is expected to grow with a CAGR of 6.5% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the equine veterinary therapeutic market?
Answer: The major drivers for this market are rise in horse racing and other equestrian activities, the growing prevalence of equine ailments, and the rising costs associated with novel treatments' research and development.
Q3. What are the major segments for equine veterinary therapeutic market?
Answer: The future of the global equine veterinary therapeutic market looks promising with opportunities in the veterinary hospital, veterinary clinic, pharmacy and drug store, and e-commerce markets.
Q4. Who are the key equine veterinary therapeutic market companies?
Answer: Some of the key equine veterinary therapeutic companies are as follows:
• Merck Animal Heath
• Affymetrix
• Elanco Animal Health
• Zoetis (Pfizer Animal Health)
• Equine Health
Q5. Which equine veterinary therapeutic market segment will be the largest in future?
Answer: Lucintel forecasts that topical is expected to witness the highest growth over the forecast period due to growing demand for anti-infectives, pain relievers, and digestive aid products.
Q6. In equine veterinary therapeutic market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to growing demanf for anti-infectives, vaccinations, pain medications, digestive aids, and strong research and development industry in the region.
Q.7 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the equine veterinary therapeutic market by drug (anti- inflammatory, anti - infective, parasiticides, and others), vaccines (recombinant vaccines, inactivated vaccines, live attenuated vaccines, and others), route of administration (oral, parental, and topical), distribution channel (veterinary hospital, veterinary clinics, pharmacies & drug stores, e-commerce, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Equine Veterinary Therapeutic Market, Equine Veterinary Therapeutic Market Size, Equine Veterinary Therapeutic Market Growth, Equine Veterinary Therapeutic Market Analysis, Equine Veterinary Therapeutic Market Report, Equine Veterinary Therapeutic Market Share, Equine Veterinary Therapeutic Market Trends, Equine Veterinary Therapeutic Market Forecast, Equine Veterinary Therapeutic Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.